Nippon ShinyakuNippon Shinyaku Co.,Ltd.4516東証プライム医薬品FY ending Mar 2024, consolidated, IFRS
Revenue changed +2.8% from the prior year.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and ending equity; net assets approximate parent equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2020 | 14.5% | 0.64× | 9.3% | 1.24× | 11.5% |
| 2022 | 18.2% | 0.63× | 11.4% | 1.24× | 14.1% |
| 2023 | — | —× | 10.0% | —× | — |
| 2024 | 17.4% | 0.59× | 10.3% | 1.14× | 11.7% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2020 | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 |
|---|---|---|---|---|
| Revenue | 116,637 | 137,484 | 144,175 | 148,255 |
| Cost of revenue | 53,155 | — | — | — |
| Gross profit | 63,481 | — | — | — |
| SG&A | 41,813 | — | — | — |
| Operating income | 21,668 | — | — | — |
| Pretax income | 22,442 | 33,301 | 30,489 | 33,616 |
| Income tax | 5,553 | — | — | — |
| Net income attributable to owners | 16,866 | 24,986 | 22,812 | 25,851 |
| Operating margin | 18.6% | — | — | — |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
| Item | FY ending Mar 2020 | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 |
|---|---|---|---|---|
| Cash and equivalents | ¥43.6B | ¥60.6B | ¥60B | ¥58.1B |
| Total assets | ¥181.5B | ¥219.9B | ¥237.5B | ¥263.4B |
| Net assets | ¥146.9B | ¥176.8B | — | ¥220.5B |
| Share capital | ¥5.17B | — | — | — |
| Trade receivables | ¥40.9B | — | — | — |
| Property, plant and equipment | ¥26.1B | — | — | — |
| Intangible assets excluding goodwill | ¥546M | — | — | — |
| Investment securities | ¥18.9B | — | — | — |
| Current assets | ¥120.8B | — | — | — |
| Current liabilities | ¥25B | — | — | — |
| Trade payables | ¥11.2B | — | — | — |
| Total liabilities | ¥34.7B | — | — | — |
| Non-controlling interests | ¥269M | — | — | — |
| Equity attributable to owners of parent | ¥146.6B | — | — | — |
| Retained earnings | ¥132.1B | — | — | — |
| Treasury stock | -¥2.47B | — | — | — |
EDINET (FSA Japan)
有価証券報告書－第163期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第161期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第159期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
訂正有価証券報告書－第158期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 10 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.